Skip to main content
. 2025 Jul 24;16(11):3343–3354. doi: 10.7150/jca.115507

Table 1.

Patient information from TCGA and GSE47994 (n=249 patients)

Variables No. Patients (%)
Gender
Female 249 (100.0%)
Male 0 (0.0%)
Age (y)
≤ 55 147 (59.0%)
>55 102 (41.0%)
Tumor size
T1 53 (21.3%)
T2 168 (67.5%)
T3 18 (7.2%)
T4 10 (4.0%)
Nodal status
N0 113 (45.4%)
N1 74 (29.7%)
N2 43 (17.3%)
N3 19 (7.6%)
Metastasis
M0 132 (53.0%)
M1 102 (41.0%)
Mx 15 (6.0%)
Pathological grade
G1 35 (14.1%)
G2 73 (29.3%)
G3 141 (56.6%)
Stage
I 50 (20.1%)
II 79 (31.6%)
III 68 (27.3%)
IV 102 (41.0%)
Ki-67
< 15% 43 (17.3%)
≥ 15% 206 (82.7%)